Related by context. All words. (Click for frequent words.) 73 hepatitis C virus HCV 71 Hepatitis C virus 70 HCV infection 70 human immunodeficiency virus 70 HCV 69 hepatitis B virus HBV 67 hepatitis C 65 chronic hepatitis C 64 HBV 63 Hepatitis B virus 63 chronic HCV infection 62 peginterferon 62 hepatitis C infection 62 chronic HCV 62 Epstein Barr virus EBV 62 hepatitis C genotype 62 herpes simplex virus 61 Hepatitis C virus HCV 61 hepatitis C HCV 61 hepatitis B virus 61 Helicobacter pylori H. pylori 61 CD8 responses 61 BRAF mutation 60 TB bacterium 60 HCV infections 60 HPV# 60 CCR5 antagonist 60 nucleoside analogues 60 HBV infection 60 viral replication 59 HCV genotype 1 59 protease inhibitor 59 interferon 59 Chlamydia trachomatis 59 latent TB infection 59 neutralizing antibodies 59 HIV 59 entecavir 59 cytomegalovirus CMV 59 AEG# 59 antibody 59 pegylated interferon 59 antiviral therapy 59 HCV infected 59 VZV 59 H. pylori 59 TMC# [001] 58 Hepatitis C 58 hepatitis C. 58 chronic HBV infection 58 CCR5 tropic HIV 58 tyrosine kinase inhibitor 58 Candida species 58 nitazoxanide 58 latent TB 58 HIV infection 58 multidrug resistance 58 virotherapy 58 Plasmodium parasites 58 CMV disease 58 viral load 58 HCV genotypes 58 LTBI 58 integrase inhibitor 58 recurrent genital herpes 58 BRAF gene 57 antisense drug 57 S. aureus infections 57 latent tuberculosis infection 57 Raltegravir 57 antiviral therapies 57 nucleotide analog 57 Mycobacterium tuberculosis 57 parasite Trypanosoma cruzi 57 Helicobacter 57 viremia 57 Amigal 57 immunomodulator 57 Hedgehog pathway 57 Plasmodium falciparum 57 Staphylococcus aureus infections 57 Hepatitis B virus HBV 57 FLT3 57 daptomycin 57 neutralizing antibody 57 Respiratory Syncytial Virus RSV 57 M#V mutation 57 chlamydial infection 57 CMV infection 57 virus HCV infection 57 raltegravir 57 CCR5 receptor antagonist 57 Salmonella typhi 57 sustained virologic response 57 JAK3 57 hepatitis B infection 57 NRTI resistance 57 NNRTIs 57 HIV infected 57 HPV infections 57 replicon 56 multidrug resistant 56 HSV1 56 inhibit replication 56 tuberculosis bacterium 56 Elvitegravir 56 malaria parasites 56 Telbivudine 56 pneumococci 56 lamivudine 56 latent infection 56 HBsAg 56 multidrug resistant strains 56 fluoroquinolone resistance 56 latent tuberculosis 56 viral suppression 56 Velcade bortezomib 56 oral antiviral 56 Enzastaurin 56 IgG antibodies 56 combination antiretroviral therapy 56 Streptococcus pneumoniae 56 NRTI 56 malaria parasite 56 Cryptococcus neoformans 56 chronic hepatitis B. 56 viral subtypes 56 chronically infected 56 M.tb 56 H pylori 56 TRIM5a 56 measles virus 56 genital ulcer disease 56 S. aureus colonization 56 Protease inhibitors 56 telaprevir 56 mycobacterium tuberculosis 56 TTR gene 56 rotaviruses 56 hedgehog pathway 56 clade B 56 AAV2 56 Genital herpes 56 HuLuc# 56 chronic HBV 56 candidemia 56 Helicobacter pylori 56 dengue viruses 56 chronic hepatitis B 56 TNFa 56 Kaposi sarcoma 56 polymerase inhibitors 56 Hemopurifier 56 GBV C 56 Hepatitis C HCV 56 maraviroc 56 interferon alpha 56 P. vivax malaria 55 inhibitor RG# 55 TB bacillus 55 HCV polymerase inhibitor 55 Boceprevir 55 P. falciparum parasites 55 nucleotide analogue 55 MDR tuberculosis 55 Vesivirus 55 CCL#L# 55 EBV infection 55 OHR/AVR# 55 hepatocellular carcinoma 55 P. falciparum 55 PROSTVAC VF 55 myeloma cells 55 HAART 55 virus HCV 55 Tarvacin 55 varicella zoster virus VZV 55 S. pneumoniae 55 P. vivax 55 NS5b 55 ImmunoVEX HSV2 55 EGFRvIII 55 BCR ABL 55 antibodies 55 Hepatitis C Virus HCV 55 varicella zoster virus 55 tuberculosis TB 55 NNRTI 55 bevirimat 55 interferons 55 superinfection 55 P. reichenowi 55 Epivir 55 Plasmodium 55 bacterial pathogen 55 interferon gamma 55 CLL cells 55 ALN RSV# 55 Sym# 55 CXCR4 55 posaconazole 55 OncoVEX GM CSF 55 reinfection 55 tipranavir ritonavir 55 CCR5 mutation 55 genital herpes infections 55 P aeruginosa 55 WT1 55 immunosuppressive therapies 55 H. influenzae 55 lupus nephritis 55 latent tuberculosis TB 55 cytomegalovirus 55 Telaprevir 55 HQK 55 HBV DNA 55 nucleoside analogue 55 herpes simplex 55 MDM2 55 BRAF protein 55 Cytomegalovirus CMV 55 virus XMRV 55 HCV replication 55 HBeAg negative 55 Hepatitis C Virus 55 CCR5 tropic 55 Adenovirus 55 Epstein Barr Virus EBV 55 HSV2 55 pegylated interferon alpha 55 defensins 55 ribavirin therapy 55 JAK2 enzyme 55 rifamycins 55 virologic failure 55 E. faecalis 55 immunosuppressed patients 55 tumor necrosis factor 55 rituximab Rituxan 55 adenoviral 55 adefovir 55 pentamidine 55 KSHV 55 chemokine receptors 55 Recombinant interferon alpha 55 viraemia 54 human monoclonal antibody 54 non nucleoside HCV 54 parainfluenza virus 54 GVHD 54 T#I [002] 54 TB germ 54 elvitegravir 54 attenuated strain 54 EGF receptor 54 HIV RNA 54 Omacetaxine 54 reverse transcriptase enzyme 54 interferon pathway 54 nelfinavir 54 antigen 54 NS#/#A protease 54 humanized monoclonal antibody 54 Typhi 54 CD8 T cells 54 HCMV 54 protease inhibitors 54 Epstein Barr virus 54 ADAMTS# 54 methicillin resistant S. aureus 54 myelofibrosis polycythemia vera 54 Reverset 54 chlamydial 54 Gleevec resistant 54 H. pylori infection 54 serotype #A 54 NNRTI resistance 54 oral prodrug 54 CYT# potent vascular disrupting 54 C. trachomatis 54 Interferon 54 Trypanosoma brucei 54 JAK inhibitor 54 Symadex 54 Dasatinib 54 Sapacitabine 54 Cethromycin 54 vWD 54 decitabine 54 mAb 54 protein kinase inhibitor 54 transgenic rats 54 Duchenne muscular dystrophy DMD 54 T. cruzi 54 N. meningitidis 54 ribavirin 54 Human papillomavirus HPV 54 telbivudine 54 T#I mutant 54 reverse transcriptase 54 Vacc 4x 54 Plasmodium parasite 54 Hepatitis B Virus 54 mycobacterium 54 rhinovirus infection 54 malarial parasites 54 GSK3 54 S. aureus 54 apricitabine 54 hematological malignancy 54 chronic hepatitis 54 EGFR inhibitors 54 Plasmodium ovale 54 Naive Patients 54 virus 54 cytokine Interleukin 54 viral strains 54 Zolinza 54 TB bacilli 54 Dengue virus 54 invasive aspergillosis 54 retrovirus 54 Shiga toxin 54 Staphylococcus aureus MRSA 54 NS4A 54 meningococcal bacteria 54 serum HBV DNA 54 alkylating agent 54 GPR# [002] 54 MYDICAR ® 54 TAT2 54 leukemia ALL 54 protease inhibitor mutations 54 Myelodysplastic Syndrome MDS 54 antibody mediated 54 immune responses 54 nucleotide analogs 54 CMV infections 54 CCR5 inhibitors 54 Alinia 54 B lymphocytes 54 ketolide antibiotic 54 K ras mutations 54 endostatin 54 cidofovir 54 CMV 54 naive HCV genotype 54 anti TNF 54 herpesviruses 54 efavirenz Sustiva 54 ALN TTR 54 CMV retinitis 54 pneumococcal infection 54 PKC beta 54 S. aureus bacteria 54 Retroviral 54 PRT# 54 CCR5 antagonists 54 CCR5 inhibitor 54 WNV infection 54 PEG Interferon lambda 54 malarial parasite 54 Bcr Abl mutations 54 ViroChem 53 Herpes simplex virus 53 HAART regimen 53 Chagas disease 53 TNF alpha antagonist 53 small molecule inhibitors 53 C. neoformans 53 Anopheles gambiae mosquitoes 53 HCV SPRINT 53 sCD# 53 S. aureus isolates 53 snail fever 53 Valcyte 53 genital HPV 53 protein tyrosine phosphatase 1B 53 coinfected 53 HDAC 53 humanized antibody 53 antiviral compounds 53 nifurtimox 53 Gleevec imatinib 53 Skp2 53 antiviral activity 53 HPV-#/# 53 hepatitis B 53 Mycobacterium tuberculosis TB 53 Crizotinib 53 mAbs 53 chronic myeloid leukemia CML 53 Cholangiocarcinoma 53 dengue virus 53 enteroviruses 53 fungal meningitis 53 Chlamydia infection 53 HTLV 53 immunotoxin 53 HCV replicon 53 GPNMB 53 Alemtuzumab 53 PTLD 53 isoniazid 53 Pseudomonas aeruginosa infections 53 Viramidine 53 imatinib Gleevec 53 CCX# 53 associated lymphoid tissue 53 relapsed leukemia 53 M. pneumoniae 53 neuraminidase inhibitor 53 idiopathic pulmonary fibrosis IPF 53 Sustiva efavirenz 53 Hemophilia B 53 Staphylococcus aureus bacteria 53 herpes zoster shingles 53 GNAQ 53 plasmodium parasite 53 clusterin 53 retroviral 53 monoclonal antibody MAb 53 Escherichia coli Klebsiella pneumoniae 53 PARP inhibitors 53 HAART regimens 53 superantigens 53 acinetobacter 53 PTP1B 53 cilengitide 53 CDDO Im 53 PLX# 53 Chlamydia pneumoniae 53 plasma kallikrein 53 bacterium Neisseria meningitidis 53 genital ulcers 53 PegIFN RBV 53 integrase 53 pathogen 53 simian virus 53 human herpesvirus 53 anti tubercular 53 peginterferon alfa 2a 53 viral loads 53 TNFα 53 REP# 53 HLA B 53 natalizumab 53 Trichomonas vaginalis 53 refractory gout 53 malaria parasite Plasmodium falciparum 53 undetectable viral loads 53 lymphocytic choriomeningitis virus LCMV 53 Blinatumomab 53 NXL# 53 sexually transmitted HPV 53 viral kinetics 53 flavopiridol 53 GBM tumors 53 Darapladib 53 vesicular stomatitis virus 53 antiviral 53 S. aureus infection 53 Daclizumab 53 HepaGam B 53 lymphocytic choriomeningitis virus 53 drug resistant strains 53 tuberculin skin testing 53 MRSA strains 53 Candida infections 53 H.I.V. 53 nonvaccine 53 lopinavir 53 pyrazinamide 53 amphotericin B 53 reverse transcriptase inhibitors 53 murine leukemia virus 53 imatinib therapy 53 pegylated interferons 53 LRP5 53 Maraviroc 53 Lassa virus 53 gastric carcinogenesis 53 PROCHYMAL 53 Cytomegalovirus 53 dual tropic 53 HBV vaccine 53 Oritavancin 53 superficial bladder cancer 53 monoclonal antibody mAb 53 BCL#A 53 MIF protein 53 Olaparib 53 chronic HCV genotype 53 lymphomas 53 Janus kinase 53 HTS assay 53 HCV polymerase 53 metastatic malignant melanoma 53 latently infected 53 active antiretroviral therapy 53 Plasmodium vivax 53 HCV RNA 53 DXL# 53 polymerase inhibitor 53 nucleoside 53 T#I mutation 53 chemoresistance 53 Talabostat 53 breast cancer metastasis 53 invasive candidiasis 53 candidiasis 53 Chronic hepatitis B 53 Rituximab 53 idarubicin 53 DENV 53 investigational integrase inhibitor 53 Clostridium difficile infection 53 Gag polymorphisms 53 activin 53 nanoviricide 53 N. gonorrhoeae 53 CTLA 4 53 siRNA 53 PSMA ADC 53 solithromycin 53 CXCR4 receptor 53 treatment naïve genotype 53 SIV infection 53 fungal organisms 53 Candida infection 53 influenza virus 53 H#Y 53 EGFR receptor 53 recurrent ovarian cancer 53 HPV subtypes 53 visilizumab 53 Gilead Viread 53 Entecavir 53 artemisinin derivative 53 CCR2 52 Neisseria gonorrhoeae 52 log# reduction 52 liver scarring 52 azoles 52 P. aeruginosa 52 ALDH2 52 cirrhosis liver failure 52 miltefosine 52 Pneumocystis 52 bacterium Mycobacterium tuberculosis 52 resistant TB 52 familial ALS 52 Human Papillomavirus 52 P. aeruginosa infections 52 Human Papilloma Virus 52 infliximab 52 hypoxia inducible factor 52 Diamyd ® 52 S.aureus 52 K#R [002] 52 Azixa 52 R5 tropic 52 herpes zoster virus 52 basal cell nevus syndrome 52 midstage trials 52 Traficet EN 52 JAK2 mutation 52 tumor antigen 52 antisense drugs 52 naive HCV 52 imatinib 52 antiretroviral therapy 52 Smallpox vaccine 52 dasatinib 52 NEUGENE 52 strep bacteria 52 rituximab 52 XMRV 52 tenofovir Viread 52 mitochondrial toxicity 52 IGFBP 52 osteopontin 52 medulloblastomas 52 immunosuppressant 52 poxvirus 52 SCH # 52 nucleoside analog 52 Civacir 52 MyVax R 52 IAP inhibitors 52 therapeutic monoclonal antibody 52 ganciclovir 52 gamma secretase inhibitor 52 otelixizumab 52 papilloma virus 52 coagulase negative staphylococci 52 tigecycline 52 GRNOPC1 cells 52 hepatitis B HBV 52 K#N 52 coinfection 52 human papillomavirus HPV 52 CEQ# 52 XmAb# 52 Onconase 52 hepatoma 52 HCV protease 52 HBeAg positive 52 Aurora kinase 52 therapeutic monoclonal antibodies 52 VGV 1 52 imipenem 52 parainfluenza 52 protease inhibitor PI 52 MEK inhibitor 52 retroviral infection 52 dacetuzumab 52 GIST tumors 52 HIV protease 52 refractory CML 52 FGFR2 52 Fludase 52 bortezomib 52 Nanobodies ® 52 recurrent glioblastoma multiforme 52 PARP inhibition 52 Tumor Necrosis Factor 52 anticancer therapies 52 S. suis 52 PKM2 52 virologic 52 antiretroviral regimens 52 chronic myelogenous leukemia CML 52 Clusterin 52 HIV HCV coinfected 52 CTGF 52 oral JAK1 52 C1 INH 52 ano genital warts 52 viral pathogens 52 HPV types 52 HPV infection 52 trivalent vaccine 52 BARACLUDE R 52 radezolid 52 uPA 52 staphylococcal 52 SOD1 gene 52 Th# 52 Cyclosporine 52 opportunistic pathogens 52 Cytolin ® 52 bacterial vaginosis BV 52 SEBIVO 52 DFMO 52 disease progression 52 Imatinib 52 Shigella bacteria 52 cervical lesions 52 leukemic stem cells 52 type 1diabetes 52 pandemic influenza virus 52 S. pyogenes 52 JAK1 52 Streptococcus pneumonia 52 viral tropism 52 antiretroviral naive 52 germline mutation 52 myeloproliferative disorders 52 gastrointestinal stromal tumors 52 adalimumab Humira 52 Vpu 52 Neugene 52 rhinovirus 52 zidovudine AZT 52 thalidomide Thalomid 52 arenavirus 52 chemotherapy induced neutropenia 52 molecularly targeted 52 interferon therapy 52 ATL/TV# 52 verteporfin 52 Epidermal Growth Factor Receptor 52 ethambutol 52 eotaxin 52 efalizumab 52 simplex virus 52 trypanosomes 52 #ME# 52 mycobacterial 52 prion infection 52 EGFR mutation 52 chronic granulomatous disease 52 simian foamy virus 52 BLyS 52 undetectable HCV RNA 52 Bcr Abl 52 quinacrine 52 BAL# [001] 52 streptococcal 52 OMP #M# 52 hepatocellular carcinoma HCC 52 antibody MAb 52 prostate cancer CaP 52 rilpivirine 52 darapladib 52 Dacogen decitabine 52 T. gondii 52 Syk kinase 52 macrolides 52 pneumococcal bacteria 52 Insegia 52 staphylococcal infections 52 Carcinoid tumors 52 leukemia AML 52 Tofacitinib 52 seroconversion 52 JAK2 52 IGF 1R 52 huC# DM4 52 CCR5 receptors 52 IFN alpha 52 leukemia CLL 52 PARP inhibitor 52 FLT3 mutations 52 narcolepsy cataplexy 52 vivax malaria 52 TNF α 52 BCR ABL mutations 52 tipranavir 52 oncolytic virus 52 F. tularensis 52 S aureus 52 Herceptin trastuzumab 52 immunomodulatory 52 LCMV infection 52 immunosuppressant drug 52 praziquantel 52 interferon lambda 52 suppressive therapy 52 virological response 52 immune cells 52 TGF beta 52 parasite Plasmodium 52 outer membrane proteins 52 Elacytarabine 52 Interferon alpha 52 p# protein 52 viral genomes 52 NF kB pathway 52 monoclonal 52 intracellular pathogens 52 staphylococcus bacteria 52 streptococcus bacterium 52 mediated immunity 52 tenofovir DF 52 indinavir 52 necrotizing pneumonia 52 HIV1 52 DermaVir Patch 52 TMEM#B 52 bacterial strains 52 basiliximab 52 virus HBV 52 interleukins 52 meropenem 52 wart virus 52 gastrointestinal stromal tumors GIST 52 melanoma tumors 52 VEGF receptor 52 beta interferons 52 topotecan 52 TNF inhibitors 52 Hedgehog signaling pathway 52 FOXP3 52 lung fibrosis 52 cytokine 52 Wolbachia bacteria 52 Arranon 52 Helicobacter Pylori 52 nutlin 3a 52 protease inhibitors PIs 52 lenalidomide Revlimid R 52 virologic response 52 filoviruses 52 mertansine 52 TACI mutations 52 malignant pleural mesothelioma 52 resistant microorganisms 52 antibiotic resistant bacterial infections 52 Pneumocystis carinii pneumonia 52 PKC# 52 resistant isolates 52 MGUS 52 ADPKD 52 lapatinib Tykerb 52 LHRH antagonists 52 herpes zoster vaccine 52 childhood leukemias 52 prion disease 52 neuroendocrine cancers 52 CCR5 mAb 52 Laquinimod 52 decompensated liver disease 52 mesenchymal cell 52 B. cepacia 52 SCCHN 52 Salmonella Typhi 52 CD#L 52 HbF 51 DGAT1 51 peg IFN 51 Viread tenofovir disoproxil fumarate 51 HIV seroconversion 51 Mycograb 51 NRTIs 51 Leishmania parasite 51 interferon beta 51 nosocomial infection 51 SGLT2 51 HER2/neu 51 TRAIL receptor 51 herpes infections 51 virus HCV protease inhibitor 51 Plasmodium falciparum malaria 51 Ceftaroline 51 BARACLUDE ® 51 HCV NS3 protease 51 Tindamax R 51 immunodeficiency virus 51 Vidaza azacitidine 51 nucleoside analogs 51 ABSSSI 51 TTR amyloidosis 51 genital herpes 51 #I TM# 51 MTP inhibitor 51 selective modulator 51 acute myelogenous leukemia AML 51 P vivax 51 chronic hepatitis C. 51 SUTENT 51 metastatic cancers 51 Borrelia 51 antiretroviral therapy ART 51 forodesine 51 herpes virus 51 trastuzumab Herceptin ® 51 CD4 cells 51 pomalidomide 51 cIAI 51 relapsed MM 51 immune modulator 51 chemokine 51 investigational monoclonal antibody 51 Simian Immunodeficiency Virus 51 diabetic nephropathy 51 Chronic lymphocytic leukemia 51 heterozygous FH 51 torezolid 51 GM CSF 51 parasite Plasmodium falciparum 51 HspE7 51 dermatophytes 51 micafungin 51 oncolytic 51 bexarotene 51 EGFR pathway 51 asymptomatic carriers 51 nonnucleoside reverse transcriptase inhibitors 51 TLR9 51 chitinase 51 HCV genotype 51 hematological cancers 51 antifungal agent 51 Clostridium difficile infections 51 NNRTI resistant virus 51 integrase inhibitors 51 diabetic kidney 51 iron overload 51 Hepatocellular Carcinoma HCC 51 autoantibody 51 opportunistic pathogen 51 targeting CD# 51 CYP# [002] 51 TLR3 51 JAK2 V#F 51 iclaprim 51 interferon IFN 51 transplanted bone marrow 51 activated lymphocytes 51 fusion protein 51 TH# cells 51 thymidylate synthase 51 Virus HIV 51 PEGylated 51 C. pneumoniae 51 sarcosine 51 kidney urologic 51 investigational protease inhibitor 51 glioblastoma 51 FVIII inhibitors 51 immunocompetent 51 medulloblastoma 51 inflammatory arthritis 51 viral RNA 51 nanoviricides 51 suppressor gene 51 androgen receptor AR 51 ZNF# 51 Seliciclib 51 pDCs 51 hypereosinophilic syndrome 51 elotuzumab 51 monoclonal antibody 51 biologic DMARD 51 genetic variants associated 51 lymphoid organs 51 CBLC# 51 receptor inhibitor 51 SHPT 51 Natalizumab 51 HPV 51 CD# monoclonal antibody 51 Gleevec imatinib mesylate 51 CDAD 51 pyruvate kinase 51 AmBisome 51 influenza subtypes 51 B lymphocyte 51 proteasome inhibitors 51 HBV genotype 51 oncogenic HPV 51 small molecule inhibitor 51 pneumococcus 51 relapsed ovarian cancer 51 Septin 9 51 PIK3CA 51 HuMax CD4 51 PCSK9 51 nanoviricides ® 51 LRAT 51 antiretroviral therapies 51 Herpes Simplex Virus 51 caspofungin 51 Hepatitis C. 51 docetaxel chemotherapy 51 cervical vaginal 51 panobinostat 51 Bcl xL 51 AZT zidovudine Retrovir 51 mutated KRAS 51 CCR5 51 SSc 51 apoptotic pathway 51 DAS# [001] 51 topoisomerase 51 CFTR gene 51 mTOR pathway 51 HER2 overexpression 51 biofilm formation 51 CHIKV 51 human rhinovirus HRV 51 influenza VLP vaccine 51 immunosuppressive 51 protozoan parasite 51 pneumococcal pneumonia 51 tenofovir emtricitabine 51 treatment naive genotype 51 GSK# [002] 51 rhinovirus infections 51 refractory chronic myeloid 51 proteasome inhibitor 51 virus SIV 51 HPV strains 51 anti CD3 monoclonal 51 Epratuzumab 51 systemic lupus erythematosus 51 shRNAs 51 progressive neurodegenerative disorder 51 eIF4E 51 thrombopoietin 51 abiraterone 51 personalized immunotherapy 51 enterotoxigenic E. coli 51 liver metastases 51 Cancidas 51 immune modulating 51 pDC 51 H.pylori 51 APOL1 51 antiviral efficacy 51 telaprevir VX 51 epithelial tumors 51 IDH1 51 bacterial fungal 51 plague bacterium Yersinia 51 paclitaxel Taxol 51 riociguat